Click here to get full coverage on H.C. Wainwright Reiterated a Buy on Arrowhead Pharmaceuticals (ARWR) - MSN

H.C. Wainwright Reiterated a Buy on Arrowhead Pharmaceuticals (ARWR)  MSN

H.C. Wainwright Reiterated a Buy on Arrowhead Pharmaceuticals (ARWR) - MSN

Click here to get full coverage on Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Corebridge Financial Inc. - MarketBeat

Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Corebridge Financial Inc.  MarketBeat

Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Corebridge Financial Inc. - MarketBeat

Click here to get full coverage on Arrowhead sues Ionis over patent dispute related to lead asset - Seeking Alpha

Arrowhead sues Ionis over patent dispute related to lead asset  Seeking Alpha

Arrowhead sues Ionis over patent dispute related to lead asset - Seeking Alpha

Click here to get full coverage on Patent Battle: Arrowhead Pharmaceuticals Fights for Revolutionary FCS Treatment Against Ionis Claims - Stock Titan

Patent Battle: Arrowhead Pharmaceuticals Fights for Revolutionary FCS Treatment Against Ionis Claims  Stock Titan

Patent Battle: Arrowhead Pharmaceuticals Fights for Revolutionary FCS Treatment Against Ionis Claims - Stock Titan

Click here to get full coverage on Improved Revenues Required Before Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Stock's 37% Jump Looks Justified - simplywall.st

Improved Revenues Required Before Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Stock's 37% Jump Looks Justified  simplywall.st

Improved Revenues Required Before Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Stock's 37% Jump Looks Justified - simplywall.st

Click here to get full coverage on Arrowhead Pharmaceuticals, Inc. $ARWR Stock Holdings Cut by Russell Investments Group Ltd. - MarketBeat

Arrowhead Pharmaceuticals, Inc. $ARWR Stock Holdings Cut by Russell Investments Group Ltd.  MarketBeat

Arrowhead Pharmaceuticals, Inc. $ARWR Stock Holdings Cut by Russell Investments Group Ltd. - MarketBeat

Click here to get full coverage on Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional owners may be pleased with recent gains after 7.6% loss over the past year - Yahoo Finance

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional owners may be pleased with recent gains after 7.6% loss over the past year  Yahoo Finance

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) institutional owners may be pleased with recent gains after 7.6% loss over the past year - Yahoo Finance

Click here to get full coverage on Arrowhead (ARWR) Climbs 24.9% on $100-Million Licensing Revenue - MSN

Arrowhead (ARWR) Climbs 24.9% on $100-Million Licensing Revenue  MSN

Arrowhead (ARWR) Climbs 24.9% on $100-Million Licensing Revenue - MSN

Click here to get full coverage on Breakthrough Brain-Penetrating RNAi Drug: Arrowhead's New Alzheimer's Treatment Shows Promise in Primates - Stock Titan

Breakthrough Brain-Penetrating RNAi Drug: Arrowhead's New Alzheimer's Treatment Shows Promise in Primates  Stock Titan

Breakthrough Brain-Penetrating RNAi Drug: Arrowhead's New Alzheimer's Treatment Shows Promise in Primates - Stock Titan

Click here to get full coverage on Hsbc Holdings PLC Invests $173,000 in Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Hsbc Holdings PLC Invests $173,000 in Arrowhead Pharmaceuticals, Inc. $ARWR  MarketBeat

Hsbc Holdings PLC Invests $173,000 in Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Click here to get full coverage on Jim Cramer on Arrowhead Pharmaceuticals (ARWR): “It Doesn’t Make Any Money” - Yahoo Finance

Jim Cramer on Arrowhead Pharmaceuticals (ARWR): “It Doesn’t Make Any Money”  Yahoo Finance

Jim Cramer on Arrowhead Pharmaceuticals (ARWR): “It Doesn’t Make Any Money” - Yahoo Finance

Click here to get full coverage on Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by MetLife Investment Management LLC - MarketBeat

Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by MetLife Investment Management LLC  MarketBeat

Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by MetLife Investment Management LLC - MarketBeat

Click here to get full coverage on Arrowhead Pharma (ARWR) Shares Dragged by Sarepta Concerns - Yahoo Finance

Arrowhead Pharma (ARWR) Shares Dragged by Sarepta Concerns  Yahoo Finance

Arrowhead Pharma (ARWR) Shares Dragged by Sarepta Concerns - Yahoo Finance

Click here to get full coverage on Zacks Small Cap Has Pessimistic View of ARWR FY2025 Earnings - MarketBeat

Zacks Small Cap Has Pessimistic View of ARWR FY2025 Earnings  MarketBeat

Zacks Small Cap Has Pessimistic View of ARWR FY2025 Earnings - MarketBeat

Click here to get full coverage on Why Arrowhead Pharmaceuticals, Inc. (ARWR) is Among the Best Small Cap Stocks to Buy with the Biggest Upside Potential - Yahoo Finance

Why Arrowhead Pharmaceuticals, Inc. (ARWR) is Among the Best Small Cap Stocks to Buy with the Biggest Upside Potential  Yahoo Finance

Why Arrowhead Pharmaceuticals, Inc. (ARWR) is Among the Best Small Cap Stocks to Buy with the Biggest Upside Potential - Yahoo Finance

Click here to get full coverage on Equities Analysts Set Expectations for ARWR FY2026 Earnings - MarketBeat

Equities Analysts Set Expectations for ARWR FY2026 Earnings  MarketBeat

Equities Analysts Set Expectations for ARWR FY2026 Earnings - MarketBeat

Click here to get full coverage on Arrowhead Pharmaceuticals (NASDAQ:ARWR) Hits New 12-Month High - Should You Buy? - MarketBeat

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Hits New 12-Month High - Should You Buy?  MarketBeat

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Hits New 12-Month High - Should You Buy? - MarketBeat

Click here to get full coverage on Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Northern Trust Corp - MarketBeat

Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Northern Trust Corp  MarketBeat

Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Northern Trust Corp - MarketBeat

Click here to get full coverage on ADAR1 Capital Management LLC Acquires 43,400 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

ADAR1 Capital Management LLC Acquires 43,400 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR  MarketBeat

ADAR1 Capital Management LLC Acquires 43,400 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Click here to get full coverage on Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal - Yahoo Finance

Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal  Yahoo Finance

Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal - Yahoo Finance

Click here to get full coverage on Arrowhead Pharmaceuticals (NASDAQ:ARWR) Earns "Buy" Rating from HC Wainwright - MarketBeat

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Earns "Buy" Rating from HC Wainwright  MarketBeat

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Earns "Buy" Rating from HC Wainwright - MarketBeat

Click here to get full coverage on BofA Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $42 - 富途牛牛

BofA Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $42  富途牛牛

BofA Securities Maintains Arrowhead Pharmaceuticals(ARWR.US) With Buy Rating, Raises Target Price to $42 - 富途牛牛

Click here to get full coverage on Arrowhead Pharmaceuticals (ARWR) Is Up 24.9% After Reporting Nine-Month Profitability on Surging Sales - simplywall.st

Arrowhead Pharmaceuticals (ARWR) Is Up 24.9% After Reporting Nine-Month Profitability on Surging Sales  simplywall.st

Arrowhead Pharmaceuticals (ARWR) Is Up 24.9% After Reporting Nine-Month Profitability on Surging Sales - simplywall.st

Click here to get full coverage on $ARWR stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

$ARWR stock is up 10% today. Here's what we see in our data.  Quiver Quantitative

$ARWR stock is up 10% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Insider Sale: Chief Medical Officer of $ARWR Sells 15,000 Shares - Quiver Quantitative

Insider Sale: Chief Medical Officer of $ARWR Sells 15,000 Shares  Quiver Quantitative

Insider Sale: Chief Medical Officer of $ARWR Sells 15,000 Shares - Quiver Quantitative

Click here to get full coverage on Arrowhead Pharma Jumps After Inking A Deal Worth Up To $2.2 Billion - Investor's Business Daily

Arrowhead Pharma Jumps After Inking A Deal Worth Up To $2.2 Billion  Investor's Business Daily

Arrowhead Pharma Jumps After Inking A Deal Worth Up To $2.2 Billion - Investor's Business Daily

Click here to get full coverage on Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is favoured by institutional owners who hold 70% of the company - Yahoo Finance

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is favoured by institutional owners who hold 70% of the company  Yahoo Finance

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is favoured by institutional owners who hold 70% of the company - Yahoo Finance

Click here to get full coverage on Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Up 11% - Still a Buy? - MarketBeat

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Up 11% - Still a Buy?  MarketBeat

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Up 11% - Still a Buy? - MarketBeat

Click here to get full coverage on Arrowhead Pharmaceuticals Inc (ARWR) Q2 2025 Earnings Call Highlights: Strong Financials and ... - Yahoo Finance

Arrowhead Pharmaceuticals Inc (ARWR) Q2 2025 Earnings Call Highlights: Strong Financials and ...  Yahoo Finance

Arrowhead Pharmaceuticals Inc (ARWR) Q2 2025 Earnings Call Highlights: Strong Financials and ... - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $ARWR Given $80.0 Price Target - Quiver Quantitative

New Analyst Forecast: $ARWR Given $80.0 Price Target  Quiver Quantitative

New Analyst Forecast: $ARWR Given $80.0 Price Target - Quiver Quantitative

Click here to get full coverage on Arrowhead: Upcoming Plozasiran PDUFA Review Date And Subsequent Expansion In Place (ARWR) - Seeking Alpha

Arrowhead: Upcoming Plozasiran PDUFA Review Date And Subsequent Expansion In Place (ARWR)  Seeking Alpha

Arrowhead: Upcoming Plozasiran PDUFA Review Date And Subsequent Expansion In Place (ARWR) - Seeking Alpha

Click here to get full coverage on ARROWHEAD PHARMACEUTICALS Earnings Results: $ARWR Reports Quarterly Earnings | ARWR Stock News - Quiver Quantitative

ARROWHEAD PHARMACEUTICALS Earnings Results: $ARWR Reports Quarterly Earnings | ARWR Stock News  Quiver Quantitative

ARROWHEAD PHARMACEUTICALS Earnings Results: $ARWR Reports Quarterly Earnings | ARWR Stock News - Quiver Quantitative

Click here to get full coverage on Arrowhead Pharmaceuticals Inc (ARWR) Q1 2025 Earnings Call Highlights: Strategic Collaborations ... - Yahoo Finance

Arrowhead Pharmaceuticals Inc (ARWR) Q1 2025 Earnings Call Highlights: Strategic Collaborations ...  Yahoo Finance

Arrowhead Pharmaceuticals Inc (ARWR) Q1 2025 Earnings Call Highlights: Strategic Collaborations ... - Yahoo Finance

Click here to get full coverage on ARWR: Multiple Value Drivers for Long-Term Growth… - Yahoo Finance

ARWR: Multiple Value Drivers for Long-Term Growth…  Yahoo Finance

ARWR: Multiple Value Drivers for Long-Term Growth… - Yahoo Finance

Click here to get full coverage on New Analyst Forecast: $ARWR Given $38.0 Price Target | ARWR Stock News - Quiver Quantitative

New Analyst Forecast: $ARWR Given $38.0 Price Target | ARWR Stock News  Quiver Quantitative

New Analyst Forecast: $ARWR Given $38.0 Price Target | ARWR Stock News - Quiver Quantitative

Click here to get full coverage on Arrowhead Pharmaceuticals Sets Q3 Earnings Date: What Biotech Investors Should Mark on Their Calendar - Stock Titan

Arrowhead Pharmaceuticals Sets Q3 Earnings Date: What Biotech Investors Should Mark on Their Calendar  Stock Titan

Arrowhead Pharmaceuticals Sets Q3 Earnings Date: What Biotech Investors Should Mark on Their Calendar - Stock Titan

Click here to get full coverage on Insiders At Arrowhead Pharmaceuticals Sold US$3.1m In Stock, Alluding To Potential Weakness - simplywall.st

Insiders At Arrowhead Pharmaceuticals Sold US$3.1m In Stock, Alluding To Potential Weakness  simplywall.st

Insiders At Arrowhead Pharmaceuticals Sold US$3.1m In Stock, Alluding To Potential Weakness - simplywall.st

Click here to get full coverage on Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement - Business Wire

Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement  Business Wire

Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement - Business Wire

Click here to get full coverage on Arrowhead (ARWR) Stock Soars over $200M Deal with Swiss Pharma Giant Novartis - TipRanks

Arrowhead (ARWR) Stock Soars over $200M Deal with Swiss Pharma Giant Novartis  TipRanks

Arrowhead (ARWR) Stock Soars over $200M Deal with Swiss Pharma Giant Novartis - TipRanks

Click here to get full coverage on Invesco Ltd. Buys 137,845 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Invesco Ltd. Buys 137,845 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR  MarketBeat

Invesco Ltd. Buys 137,845 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Click here to get full coverage on Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results - Stock Titan

Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results  Stock Titan

Arrowhead Pharmaceuticals Reports Fiscal 2025 Second Quarter Results - Stock Titan

Click here to get full coverage on Arrowhead Pharmaceuticals Is Finally Arriving (NASDAQ:ARWR) - Seeking Alpha

Arrowhead Pharmaceuticals Is Finally Arriving (NASDAQ:ARWR)  Seeking Alpha

Arrowhead Pharmaceuticals Is Finally Arriving (NASDAQ:ARWR) - Seeking Alpha

Click here to get full coverage on Jump Financial LLC Sells 52,755 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Jump Financial LLC Sells 52,755 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR  MarketBeat

Jump Financial LLC Sells 52,755 Shares of Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Click here to get full coverage on Magnetar Financial LLC Boosts Stock Position in Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Magnetar Financial LLC Boosts Stock Position in Arrowhead Pharmaceuticals, Inc. $ARWR  MarketBeat

Magnetar Financial LLC Boosts Stock Position in Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Click here to get full coverage on Arrowhead Pharmaceuticals: A Reluctant Sell Rating Explained (Rating Downgrade) (ARWR) - Seeking Alpha

Arrowhead Pharmaceuticals: A Reluctant Sell Rating Explained (Rating Downgrade) (ARWR)  Seeking Alpha

Arrowhead Pharmaceuticals: A Reluctant Sell Rating Explained (Rating Downgrade) (ARWR) - Seeking Alpha

Click here to get full coverage on Arrowhead Pharmaceuticals, Inc. $ARWR Shares Bought by Rafferty Asset Management LLC - MarketBeat

Arrowhead Pharmaceuticals, Inc. $ARWR Shares Bought by Rafferty Asset Management LLC  MarketBeat

Arrowhead Pharmaceuticals, Inc. $ARWR Shares Bought by Rafferty Asset Management LLC - MarketBeat

Click here to get full coverage on How The Negative Developments At Sarepta Therapeutics Impact Arrowhead Pharmaceuticals - Seeking Alpha

How The Negative Developments At Sarepta Therapeutics Impact Arrowhead Pharmaceuticals  Seeking Alpha

How The Negative Developments At Sarepta Therapeutics Impact Arrowhead Pharmaceuticals - Seeking Alpha

Click here to get full coverage on Is Arrowhead Pharmaceuticals (NASDAQ:ARWR) Using Too Much Debt? - simplywall.st

Is Arrowhead Pharmaceuticals (NASDAQ:ARWR) Using Too Much Debt?  simplywall.st

Is Arrowhead Pharmaceuticals (NASDAQ:ARWR) Using Too Much Debt? - simplywall.st

Click here to get full coverage on Siren L.L.C. Has $34.01 Million Holdings in Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Siren L.L.C. Has $34.01 Million Holdings in Arrowhead Pharmaceuticals, Inc. $ARWR  MarketBeat

Siren L.L.C. Has $34.01 Million Holdings in Arrowhead Pharmaceuticals, Inc. $ARWR - MarketBeat

Click here to get full coverage on Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Up 9.3% - Still a Buy? - MarketBeat

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Up 9.3% - Still a Buy?  MarketBeat

Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Up 9.3% - Still a Buy? - MarketBeat

Click here to get full coverage on Arrowhead Pharmaceuticals Sues Ionis Over Patent Dispute - TipRanks

Arrowhead Pharmaceuticals Sues Ionis Over Patent Dispute  TipRanks

Arrowhead Pharmaceuticals Sues Ionis Over Patent Dispute - TipRanks

Click here to get full coverage on Arrowhead Pharmaceuticals Inc. (ARWR) reports earnings - Quartz

Arrowhead Pharmaceuticals Inc. (ARWR) reports earnings  Quartz

Arrowhead Pharmaceuticals Inc. (ARWR) reports earnings - Quartz

Click here to get full coverage on SA analyst downgrades: PLTR, PSTG, NTLA, ARWR - Seeking Alpha

SA analyst downgrades: PLTR, PSTG, NTLA, ARWR  Seeking Alpha

SA analyst downgrades: PLTR, PSTG, NTLA, ARWR - Seeking Alpha

Click here to get full coverage on Arrowhead Pharmaceuticals Redeems Approximately $50 Million of Arrowhead Stock and Will Receive Approximately $50 Million in Cash in Satisfaction of Milestone from Sarepta Therapeutics - Business Wire

Arrowhead Pharmaceuticals Redeems Approximately $50 Million of Arrowhead Stock and Will Receive Approximately $50 Million in Cash in Satisfaction of Milestone from Sarepta Therapeutics  Business Wire

Arrowhead Pharmaceuticals Redeems Approximately $50 Million of Arrowhead Stock and Will Receive Approximately $50 Million in Cash in Satisfaction of Milestone from Sarepta Therapeutics - Business Wire

Click here to get full coverage on Arrowhead Pharmaceuticals Redeems Approximately $50 Million of Arrowhead Stock and Will Receive Approximately $50 Million in Cash in Satisfaction of Milestone from Sarepta Therapeutics - BioSpace

Arrowhead Pharmaceuticals Redeems Approximately $50 Million of Arrowhead Stock and Will Receive Approximately $50 Million in Cash in Satisfaction of Milestone from Sarepta Therapeutics  BioSpace

Arrowhead Pharmaceuticals Redeems Approximately $50 Million of Arrowhead Stock and Will Receive Approximately $50 Million in Cash in Satisfaction of Milestone from Sarepta Therapeutics - BioSpace

Click here to get full coverage on Arrowhead expects Sarepta to meet deal terms (ARWR:NASDAQ) - Seeking Alpha

Arrowhead expects Sarepta to meet deal terms (ARWR:NASDAQ)  Seeking Alpha

Arrowhead expects Sarepta to meet deal terms (ARWR:NASDAQ) - Seeking Alpha

Click here to get full coverage on Sarepta Sells Arrowhead Stake To Stretch Its Cash Runway; And One Stock Dives - Investor's Business Daily

Sarepta Sells Arrowhead Stake To Stretch Its Cash Runway; And One Stock Dives  Investor's Business Daily

Sarepta Sells Arrowhead Stake To Stretch Its Cash Runway; And One Stock Dives - Investor's Business Daily

Click here to get full coverage on Arrowhead (ARWR) Q3 2025 Earnings Call Transcript - Mitrade

Arrowhead (ARWR) Q3 2025 Earnings Call Transcript  Mitrade

Arrowhead (ARWR) Q3 2025 Earnings Call Transcript - Mitrade

Click here to get full coverage on Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal - MSN

Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal  MSN

Arrowhead Pharmaceuticals, Inc. (ARWR) Secures $100M Milestone from Sarepta in RNAi Breakthrough Deal - MSN

Click here to get full coverage on Arrowhead Lands Billion-Dollar Biotech Deal: Stock Soars Double-Digits - Yahoo Finance

Arrowhead Lands Billion-Dollar Biotech Deal: Stock Soars Double-Digits  Yahoo Finance

Arrowhead Lands Billion-Dollar Biotech Deal: Stock Soars Double-Digits - Yahoo Finance

Click here to get full coverage on Arrowhead Pharmaceuticals: Progress During Adverse Market Conditions (NASDAQ:ARWR) - Seeking Alpha

Arrowhead Pharmaceuticals: Progress During Adverse Market Conditions (NASDAQ:ARWR)  Seeking Alpha

Arrowhead Pharmaceuticals: Progress During Adverse Market Conditions (NASDAQ:ARWR) - Seeking Alpha

Click here to get full coverage on Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases - Yahoo Finance

Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases  Yahoo Finance

Arrowhead Pharmaceuticals Stock Falls After Early-Stage Data From RNA-Based Therapeutic For Kidney Diseases - Yahoo Finance

Click here to get full coverage on Arrowhead Pharmaceuticals Inc (ARWR) Q4 2024 Earnings Call Highlights: Transformational ... - Yahoo Finance

Arrowhead Pharmaceuticals Inc (ARWR) Q4 2024 Earnings Call Highlights: Transformational ...  Yahoo Finance

Arrowhead Pharmaceuticals Inc (ARWR) Q4 2024 Earnings Call Highlights: Transformational ... - Yahoo Finance

Click here to get full coverage on Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA Programs - Sarepta Therapeutics

Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA Programs  Sarepta Therapeutics

Sarepta Therapeutics Announces Global Licensing and Collaboration Agreement with Arrowhead Pharmaceuticals for Multiple Clinical and Preclinical siRNA Programs - Sarepta Therapeutics

Click here to get full coverage on What is ARWR s 5 year growth outlook - Dividend Hike & Verified Momentum Watchlists - خودرو بانک

What is ARWR s 5 year growth outlook - Dividend Hike & Verified Momentum Watchlists  خودرو بانک

What is ARWR s 5 year growth outlook - Dividend Hike & Verified Momentum Watchlists - خودرو بانک

Click here to get full coverage on Arrowhead Pharma (ARWR) Shares Dragged by Sarepta Concerns - MSN

Arrowhead Pharma (ARWR) Shares Dragged by Sarepta Concerns  MSN

Arrowhead Pharma (ARWR) Shares Dragged by Sarepta Concerns - MSN

Click here to get full coverage on Arrowhead Pharmaceuticals Issues Statement on the Status of its Ongoing Agreement with Sarepta Therapeutics - Business Wire

Arrowhead Pharmaceuticals Issues Statement on the Status of its Ongoing Agreement with Sarepta Therapeutics  Business Wire

Arrowhead Pharmaceuticals Inc (ARWR)

Price Chart

Key Statistics

Technicals

About ARWR

Latest News

H.C. Wainwright Reiterated a Buy on Arrowhead Pharmaceuticals (ARWR) - MSN

Arrowhead Pharmaceuticals, Inc. $ARWR Shares Sold by Corebridge Financial Inc. - MarketBeat

Arrowhead sues Ionis over patent dispute related to lead asset - Seeking Alpha

Advanced Charts

Top Gainers

Top Losers